No abstract

4.87), depressive disorders (HRZ2.77, 95% CIZ1.98-3.87), substancerelated disorders (HRZ3.41, 95% CIZ1.79-6.50), and suicide and intentional self-inflected injuries (HRZ3.01, 95% CIZ1.03-8.85). Having stage IV disease was associated with increased risk of any mental health disorder but this was only significant in the <2 year time period. The only treatmentrelated factor that was associated with increased risk of mental health disorders included undergoing a bone marrow transplant; the risk was significant at all time points and increased over time with the highest risk period at 5-<10 years after diagnosis with a HR of 11.57 (95% CIZ4.47-29.96). The diagnosis of any mental health disorder among HL survivors was associated with a detrimental impact on overall survival (OS). The separation was more pronounced over time, with 10-year OS rates of 82% compared to 88% for survivors with and without mental health disorders, respectively (PZ.0026). Conclusion: HL survivors have an increased risk of a several different mental health disorders compared to a matched general population. Interestingly, the main risk factor for developing a mental health disorder is undergoing treatment with a bone marrow transplant. Our data illustrates the importance of attention to mental health in HL survivorship, particularly for patients who have to undergo salvage therapy.